Established Safety Profile Across all clinical studies, AOD-9604 demonstrated excellent safety and tolerability
Over 48 weeks, it drove up to 24% weight loss and major glycemic gains, beating both semaglutide and tirzepatide
It contains glutathione, known for its antioxidant properties, and kojic acid , which helps lighten the skin and reduce dark spots
Shotsy does not provide medical advice, diagnosis, or treatment, so consult your healthcare provider before making medical decisions about your GLP1 medication
2023, NEJM) showed 20 percent reduction in major adverse cardiovascular events, opened a separate pathway on most UHC plans